SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nwe Ni Than, Philip N. Newsome, A concise review of non-alcoholic fatty liver disease, Atherosclerosis, 2015, 239, 1, 192

    CrossRef

  2. 2
    Xiaoli Pan, Pei Wang, Jinzhuo Luo, Zhijun Wang, Yuhu Song, Jin Ye, Xiaohua Hou, Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients, Endocrine, 2015, 48, 3, 834

    CrossRef

  3. 3
    Hidetaka Morinaga, Rafael Mayoral, Jan Heinrichsdorff, Olivia Osborn, Niclas Franck, Nasun Hah, Evelyn Walenta, Gautam Bandyopadhyay, Ariane R. Pessentheiner, Tyler J. Chi, Heekyung Chung, Juliane G. Bogner-Strauss, Ronald M. Evans, Jerrold M. Olefsky, Da Young Oh, Characterization of Distinct Subpopulations of Hepatic Macrophages in HFD/Obese Mice, Diabetes, 2015, 64, 4, 1120

    CrossRef

  4. 4
    R. Afrin, S. Arumugam, V. Soetikno, R. A. Thandavarayan, V. Pitchaimani, V. Karuppagounder, R. Sreedhar, M. Harima, H. Suzuki, S. Miyashita, M. Nomoto, K. Suzuki, K. Watanabe, Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats, Free Radical Research, 2015, 49, 3, 279

    CrossRef

  5. 5
    Michal Pawlak, Philippe Lefebvre, Bart Staels, Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease, Journal of Hepatology, 2015, 62, 3, 720

    CrossRef

  6. 6
    Hyunhee Cheong, Seung Soo Lee, Jin Seong Lee, Jihoon Kim, Seong Who Kim, Woo Je Lee, Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide , Journal of Magnetic Resonance Imaging, 2015, 41, 4
  7. 7
    V. Bolón-Canedo, N. Sánchez-Maroño, A. Alonso-Betanzos, J.M. Benítez, F. Herrera, A review of microarray datasets and applied feature selection methods, Information Sciences, 2014, 282, 111

    CrossRef

  8. 8
    Pei-zhi Li, Jin-zheng Li, Min Li, Jian-ping Gong, Kun He, An efficient method to isolate and culture mouse Kupffer cells, Immunology Letters, 2014, 158, 1-2, 52

    CrossRef

  9. 9
    Chen-Yu Fan, Ming-Xing Wang, Chen-Xu Ge, Xing Wang, Jian-Mei Li, Ling-Dong Kong, Betaine supplementation protects against high-fructose-induced renal injury in rats, The Journal of Nutritional Biochemistry, 2014, 25, 3, 353

    CrossRef

  10. 10
    Anouk Funke, Marijke Schreurs, Marcela Aparicio-Vergara, Fareeba Sheedfar, Nanda Gruben, Niels J. Kloosterhuis, Ronit Shiri-Sverdlov, Albert K. Groen, Bart van de Sluis, Marten H. Hofker, Debby P.Y. Koonen, Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice, Atherosclerosis, 2014, 232, 2, 390

    CrossRef

  11. 11
    Antonios Chatzigeorgiou, Kyoung-Jin Chung, Ruben Garcia-Martin, Vasileia-Ismini Alexaki, Anne Klotzsche-von Ameln, Julia Phieler, David Sprott, Waldemar Kanczkowski, Theodora Tzanavari, Mohktar Bdeir, Sibylle Bergmann, Marc Cartellieri, Michael Bachmann, Polyxeni Nikolakopoulou, Andreas Androutsellis-Theotokis, Gabriele Siegert, Stefan R. Bornstein, Michael H. Muders, Louis Boon, Katia P. Karalis, Esther Lutgens, Triantafyllos Chavakis, Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation, Hepatology, 2014, 60, 4
  12. 12
    Xiang-wen Gong, Li-Han, Qin-he Yang, Hai-zhen Yan, Yu-pei Zhang, Yuan-yuan Li, Yong-jian Xu, Hong Wang, Jin-wen Zhang, Chun-mei Lin, Effects of Soothing Liver and Invigorating Spleen Recipe on Lipid Metabolism Disorders in Kupffer Cells of NAFLD Rats by LXRα/SREBP-1c Signal Pathway, Chinese Herbal Medicines, 2014, 6, 4, 297

    CrossRef

  13. 13
    Hirofumi Miyazaki, Tomoo Sawada, Miwa Kiyohira, Zhiqian Yu, Keiji Nakamura, Yuki Yasumoto, Yoshiteru Kagawa, Majid Ebrahimi, Ariful Islam, Kazem Sharifi, Saki Kawamura, Takanori Kodama, Yui Yamamoto, Yasuhiro Adachi, Nobuko Tokuda, Shuji Terai, Isao Sakaida, Toshizo Ishikawa, Yuji Owada, Fatty Acid Binding Protein 7 Regulates Phagocytosis and Cytokine Production in Kupffer Cells during Liver Injury, The American Journal of Pathology, 2014, 184, 9, 2505

    CrossRef

  14. 14
    Ying-Ying Yang, Pei-Chang Lee, Yi-Tsau Huang, Wei-Ping Lee, Ying-Ju Kuo, Kuei-Chuan Lee, Yun-Cheng Hsieh, Tzung-Yan Lee, Han-Chieh Lin, Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury, Clinical Science, 2014, 126, 2, 163

    CrossRef

  15. 15
    Sarita Olteanu, Michal Kandel-Kfir, Aviv Shaish, Tal Almog, Shay Shemesh, Iris Barshack, Ron N. Apte, Dror Harats, Yehuda Kamari, Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice, Digestive and Liver Disease, 2014, 46, 5, 433

    CrossRef

  16. 16
    Thomas Klein, Masato Fujii, Jan Sandel, Yuichiro Shibazaki, Kyoko Wakamatsu, Michael Mark, Hiroyuki Yoneyama, Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis, Medical Molecular Morphology, 2014, 47, 3, 137

    CrossRef

  17. 17
    Caroline C. Duwaerts, Jacquelyn J. Maher, Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis, Current Hepatology Reports, 2014, 13, 2, 119

    CrossRef

  18. 18
    Yunpeng Fan, Xiaoping Song, Yuanyuan Gao, Ying Chen, Lin Ma, Weimin Zhang, Weifeng Hou, Chao Guo, Dewen Tong, Preparation and optimization of ophiopogon polysaccharide liposome and its activity on Kupffer cells, International Journal of Pharmaceutics, 2014, 477, 1-2, 421

    CrossRef

  19. 19
    Nishika Sahini, Jürgen Borlak, Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes, Progress in Lipid Research, 2014, 54, 86

    CrossRef

  20. 20
    Fabio Marra, Frank Tacke, Roles for Chemokines in Liver Disease, Gastroenterology, 2014, 147, 3, 577

    CrossRef

  21. 21
    Yong-Hyun Han, Hyeon-Ji Kim, Eun-Jin Kim, Kyu-Seo Kim, Suckchang Hong, Hyeung-Geun Park, Mi-Ock Lee, RORα Decreases Oxidative Stress Through the Induction of SOD2 and GPx1 Expression and Thereby Protects Against Nonalcoholic Steatohepatitis in Mice, Antioxidants & Redox Signaling, 2014, 21, 15, 2083

    CrossRef

  22. 22
    Mariana Mendes-Braz, Maria Elias-Miró, Burkhard Kleuser, Susann Fayyaz, Mónica B. Jiménez-Castro, Marta Massip-Salcedo, Jordi Gracia-Sancho, Fernando S. Ramalho, Juan Rodes, Carmen Peralta, The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion, Liver International, 2014, 34, 7
  23. 23
    Christopher Depner, Kelli Lytle, Sasmita Tripathy, Donald Jump, Liver Metabolism and Fatty Liver Disease, 2014,

    CrossRef

  24. 24
    Bodil Bjørndal, Christ Berge, Marie Sannes Ramsvik, Asbjørn Svardal, Pavol Bohov, Jon Skorve, Rolf K Berge, A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation, Lipids in Health and Disease, 2013, 12, 1, 143

    CrossRef

  25. 25
    Marià Alemany, Adjustment to dietary energy availability: from starvation to overnutrition, RSC Adv., 2013, 3, 6, 1636

    CrossRef

  26. 26
    Jan Petrasek, Timea Csak, Michal Ganz, Gyongyi Szabo, Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis, Journal of Gastroenterology and Hepatology, 2013, 28,
  27. 27
    Luisa Vonghia, Peter Michielsen, Sven Francque, Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis, International Journal of Molecular Sciences, 2013, 14, 10, 19867

    CrossRef

  28. 28
    Daryl T.–Y. Lau, Amina Negash, Jie Chen, Nanette Crochet, Mala Sinha, Yuhong Zhang, Jeremie Guedj, Sharon Holder, Takeshi Saito, Stanley M. Lemon, Bruce A. Luxon, Alan S. Perelson, Michael Gale, Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection, Gastroenterology, 2013, 144, 2, 402

    CrossRef

  29. 29
    Hui-Jie Zhang, Xian-Feng Zhang, Zhi-Min Ma, Ling-Ling Pan, Zheng Chen, Hai-Wei Han, Cheng-Kun Han, Xiong-Jie Zhuang, Yan Lu, Xue-Jun Li, Shu-Yu Yang, Xiao-Ying Li, Irisin is inversely associated with intrahepatic triglyceride contents in obese adults, Journal of Hepatology, 2013, 59, 3, 557

    CrossRef

  30. 30
    Stéphane Mandard, David Patsouris, Nuclear Control of the Inflammatory Response in Mammals by Peroxisome Proliferator-Activated Receptors, PPAR Research, 2013, 2013, 1

    CrossRef

  31. 31
    Paola Dongiovanni, Luca Valenti, Peroxisome Proliferator-Activated Receptor Genetic Polymorphisms and Nonalcoholic Fatty Liver Disease: Any Role in Disease Susceptibility?, PPAR Research, 2013, 2013, 1

    CrossRef

  32. 32
    Chiung-Kuei Huang, Soo Ok Lee, Kuo-Pao Lai, Wen-Lung Ma, Tzu-Hua Lin, Meng-Yin Tsai, Jie Luo, Chawnshang Chang, Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis, Hepatology, 2013, 57, 4
  33. 33
    Jan Petrasek, Timea Csak, Gyongyi Szabo, 2013,

    CrossRef

  34. 34
    Xiaoqin Luo, Yan Yang, Tianran Shen, Xilan Tang, Yunjun Xiao, Tangbin Zou, Min Xia, Wenhua Ling, Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells, Nutrition & Metabolism, 2012, 9, 1, 34

    CrossRef

  35. 35
    Guang-Shun Chen, Hai-Zhi Qi, Effect of Kupffer cells on immune tolerance in liver transplantation, Asian Pacific Journal of Tropical Medicine, 2012, 5, 12, 970

    CrossRef

  36. 36
    Michelino Di Rosa, Lucia Malaguarnera, Genetic variants in candidate genes influencing NAFLD progression, Journal of Molecular Medicine, 2012, 90, 2, 105

    CrossRef

  37. 37
    E. Xu, A. Charbonneau, Y. Rolland, K. Bellmann, L. Pao, K. A. Siminovitch, B. G. Neel, N. Beauchemin, A. Marette, Hepatocyte-Specific Ptpn6 Deletion Protects From Obesity-Linked Hepatic Insulin Resistance, Diabetes, 2012, 61, 8, 1949

    CrossRef

  38. 38
    Xuemei Fang, Guizhen Gao, Hongyu Xue, Xingtao Zhang, Haichao Wang, In vitro and in vivo studies of the toxic effects of perfluorononanoic acid on rat hepatocytes and Kupffer cells, Environmental Toxicology and Pharmacology, 2012, 34, 2, 484

    CrossRef

  39. 39
    Gyongyi Szabo, Timea Csak, Inflammasomes in liver diseases, Journal of Hepatology, 2012, 57, 3, 642

    CrossRef

  40. 40
    Zuzana Papackova, Eliska Palenickova, Helena Dankova, Jana Zdychova, Vojtech Skop, Ludmila Kazdova, Monika Cahova, Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages, Nutrition & Metabolism, 2012, 9, 1, 22

    CrossRef

  41. 41
    Xuemei Fang, Shanshan Zou, Yuanyuan Zhao, Ruina Cui, Wei Zhang, Jiayue Hu, Jiayin Dai, Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines, Archives of Toxicology, 2012, 86, 10, 1515

    CrossRef

  42. 42
    Shengyi Sun, Yewei Ji, Sander Kersten, Ling Qi, Mechanisms of Inflammatory Responses in Obese Adipose Tissue, Annual Review of Nutrition, 2012, 32, 1, 261

    CrossRef

  43. 43
    Bolin Qin, Richard A. Anderson, Teiji Kuzuya, Yasuyuki Kitaura, Yoshiharu Shimomura, Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima fatty rats, Atherosclerosis, 2012, 222, 2, 409

    CrossRef

  44. 44
    Geoffrey C. Farrell, Derrick van Rooyen, Lay Gan, Shivrakumar Chitturi, NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications, Gut and Liver, 2012, 6, 2, 149

    CrossRef

  45. 45
    Walter Wahli, Liliane Michalik, PPARs at the crossroads of lipid signaling and inflammation, Trends in Endocrinology & Metabolism, 2012, 23, 7, 351

    CrossRef

  46. 46
    Kenneth Cusi, Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications, Gastroenterology, 2012, 142, 4, 711

    CrossRef

  47. 47
    Anne Tailleux, Kristiaan Wouters, Bart Staels, Roles of PPARs in NAFLD: Potential therapeutic targets, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012, 1821, 5, 809

    CrossRef

  48. 48
    Karen M. Kassel, Bradley P. Sullivan, Wei Cui, Bryan L. Copple, James P. Luyendyk, Therapeutic Administration of the Direct Thrombin Inhibitor Argatroban Reduces Hepatic Inflammation in Mice with Established Fatty Liver Disease, The American Journal of Pathology, 2012, 181, 4, 1287

    CrossRef

  49. 49
    Alexandre Louvet, Fatima Teixeira-Clerc, Marie-Noële Chobert, Vanessa Deveaux, Catherine Pavoine, Andreas Zimmer, Françoise Pecker, Ariane Mallat, Sophie Lotersztajn, Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice, Hepatology, 2011, 54, 4
  50. 50
    R. Broering, M. Montag, M. Jiang, M. Lu, J.-P. Sowa, K. Kleinehr, G. Gerken, J. F. Schlaak, Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state, International Immunology, 2011, 23, 9, 537

    CrossRef

  51. 51
    R Christopher Harmon, Dina G Tiniakos, Curtis K Argo, Inflammation in nonalcoholic steatohepatitis, Expert Review of Gastroenterology & Hepatology, 2011, 5, 2, 189

    CrossRef

  52. 52
    Yehuda Kamari, Aviv Shaish, Einav Vax, Shay Shemesh, Michal Kandel-Kfir, Yaron Arbel, Sarita Olteanu, Iris Barshack, Shahar Dotan, Elana Voronov, Charles A. Dinarello, Ron N. Apte, Dror Harats, Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice, Journal of Hepatology, 2011, 55, 5, 1086

    CrossRef

  53. 53
    José M Lou-Bonafonte, Carmen Arnal, Jesús Osada, New genes involved in hepatic steatosis, Current Opinion in Lipidology, 2011, 22, 3, 159

    CrossRef

  54. 54
    F. W. Kiefer, S. Neschen, B. Pfau, B. Legerer, A. Neuhofer, M. Kahle, M. Hrabé de Angelis, M. Schlederer, M. Mair, L. Kenner, J. Plutzky, M. Zeyda, T. M. Stulnig, Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice, Diabetologia, 2011, 54, 8, 2132

    CrossRef

  55. 55
    Karen M. Kassel, A. Phillip Owens, Cheryl E. Rockwell, Bradley P. Sullivan, Ruipeng Wang, Ossama Tawfik, Guodong Li, Grace L. Guo, Nigel Mackman, James P. Luyendyk, Protease-Activated Receptor 1 and Hematopoietic Cell Tissue Factor Are Required for Hepatic Steatosis in Mice Fed a Western Diet, The American Journal of Pathology, 2011, 179, 5, 2278

    CrossRef

  56. 56
    David E. Amacher, Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies, Toxicology, 2011, 279, 1-3, 10

    CrossRef

  57. 57
    N. Stefan, H.-U. Haring, The Metabolically Benign and Malignant Fatty Liver, Diabetes, 2011, 60, 8, 2011

    CrossRef

  58. 58
    Andrea Stofkova, Blanka Zelezna, Marianna Romzova, Olga Ulicna, Alexander Kiss, Martina Skurlova, Jana Jurcovicova, Effect of Feeding Status on Adjuvant Arthritis Severity, Cachexia, and Insulin Sensitivity in Male Lewis Rats, Mediators of Inflammation, 2010, 2010, 1

    CrossRef

  59. 59
    Lucía Fuentes, Tamás Rőszer, Mercedes Ricote, Inflammatory Mediators and Insulin Resistance in Obesity: Role of Nuclear Receptor Signaling in Macrophages, Mediators of Inflammation, 2010, 2010, 1

    CrossRef

  60. 60
    Bin Gao, Innate Immunity and Steatohepatitis: A Critical Role of Another Toll (TLR-9), Gastroenterology, 2010, 139, 1, 27

    CrossRef

  61. 61
    Yuan-Wen Chen, Bo-Wei Liu, Yu-Jian Zhang, Ying-Wei Chen, Guo-Fang Dong, Xiao-Dong Ding, Lei-Ming Xu, Betty Pat, Jiang-Gao Fan, Ding-Guo Li, Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver, Journal of Hepatology, 2010, 53, 3, 528

    CrossRef

  62. 62
    Kouichi Miura, Ekihiro Seki, Hirohide Ohnishi, David A. Brenner, Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease, Gastroenterology Research and Practice, 2010, 2010, 1

    CrossRef

  63. 63
    Youngmin Lee, Scott L. Friedman, Development, Differentiation and Disease of the Para-Alimentary Tract, 2010,

    CrossRef

  64. 64
    Laura J. Dixon, Mark Barnes, Hui Tang, Michele T. Pritchard, Laura E. Nagy, Kupffer Cells in the Liver, Comprehensive Physiology,